1. Document reveals scope of Operation Warp Speed and underscores vast military involvement — New data bolsters Sarepta gene therapies for two deadly muscle diseases — Inovio forced to delay planned phase 2/3 testing of COVID vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

The Darkened Sample Closet

This is a place to get together with other drug reps and discuss the industry. So pull up a chair and stay a while. Anonymous posting is allowed. For company-specific discussions, please check out our anonymous company boards.


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    17
    Views:
    534
  2. anonymous
    Replies:
    32
    Views:
    2,890
  3. anonymous
    Replies:
    2
    Views:
    237
  4. anonymous
    Replies:
    3
    Views:
    452
  5. anonymous
    Replies:
    7
    Views:
    560
  6. anonymous
    Replies:
    2
    Views:
    297
  7. anonymous
    Replies:
    6
    Views:
    680
  8. anonymous
    Replies:
    2
    Views:
    228
  9. anonymous
    Replies:
    2
    Views:
    253
  10. anonymous
    Replies:
    7
    Views:
    642
  11. anonymous
    Replies:
    24
    Views:
    3,555
  12. anonymous
    Replies:
    0
    Views:
    283
  13. anonymous
    Replies:
    1
    Views:
    378
  14. Anonymous
    Replies:
    233
    Views:
    46,938
  15. Anonymous
    Replies:
    46
    Views:
    8,253
  16. anonymous
    Replies:
    5
    Views:
    993
  17. anonymous
    Replies:
    0
    Views:
    314
  18. anonymous
    Replies:
    2
    Views:
    642
  19. anonymous
    Replies:
    0
    Views:
    542
  20. anonymous
    Replies:
    8
    Views:
    1,793

Thread Display Options

Loading...